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Abstract 
The Synthesis and Pharmacology of y-Aminobutyric Acid 
Receptor Mimetics 
Jane Anne McDonald 
y-a~nobutyric acid (GABA) has been shown to be an important 
inhibitory neurotransmitter in mammalian central nervous system (CNS). 
. . 
GABA receptors have been previously characterized in mammalian brain 
using 3H- GABA itself, a potent GABA agonist, ~-muscimol, and the GABA 
antagonist, 3H-bicuculline methiodide. Recently, it has been suggested 
that 1,2,3,6 Tetrahydropyridine-4-carboxylic acid (Isoguvacine) is a 
potent GABA receptor agonist. It has also been reported to act as a 
mixed agonist/antagonist at the GABA-benzodiazepine receptor complex. 
The binding of ~-Isoguvacine to frozen-thawed, rat brain synapto-
somal membranes has been investigated and found to be saturable, 
specific and stereospecific. The pharmacology of this ~-Isoguvacine 
binding site was seen to be consistent with an interaction at the post-
synaptic 'GABA receptor site. The effects of detergent treatment on 
this binding site-were investigated and indicated a single site, both 
in control and in Triton X-lOO treated membranes. 
A series of benzodiazepines were shown to displace 3H-Isoguvacine 
bound to frozen-thawed rat synaptosomal membranes. This effect was 
shown to be temperature-dependent and could be blocked by picrotoxinin 
(10-4 M). Pentobarbitone was also seen to displace ~-Isoguvacine 
binding, albeit at high ICSO values; an effect antagonized by picrotoxinin. 
Neither the benzodiazepines nor pentobarbitone had any effect on ~-GABA 
binding in frozen-thawed membranes. 
In contrast, using fresh rat synaptosomal membranes, neither the 
benzodiazepines nor pentobarbitone had any effect on ~-Isoguvacine 
binding, whereas both were shown to potentiate ~-GABA binding. 
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